Thinking of joining a study?

Register your interest

NCT05144126 | Not yet recruiting | Degenerative Disc Disease


Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation
Sponsor:

CeraPedics, Inc

Brief Summary:

The study intends tracking the usage patterns of a Bonegraft device within spine surgery in a multicenter setting in Canada.

Condition or disease

Degenerative Disc Disease

Intervention/treatment

CT radioraphic assessment

Phase

Not Applicable

Detailed Description:

The study wil track the usage patterns of a bone graft by identifying and classifying spine surgery procedures by access and segment type within the spins and furthet, record and analyse safety and performance measures associated with each classification. This is a post-market surveillance study}}

Study Type : Interventional
Estimated Enrollment : 300 participants
Masking : None (Open Label)
Primary Purpose : Treatment
Official Title : Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation
Actual Study Start Date : January 2022
Estimated Primary Completion Date : May 2024
Estimated Study Completion Date : September 2025
Arm Intervention/treatment

Experimental: i-Factor Arm

All patients undergoing spine fusion surgery will be treated with i-FACTOR

Other: CT radioraphic assessment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Adult patient subjects not responding to conservative management of neck / arm or back/leg pain and requiring spinal fusion between levels C1 - T2 or L1 - S1
  • Informed Consent
Exclusion Criteria
  • Hypersensitivity to i-FACTOR Bone Graft Devices
  • Adult Spinal deformity, Spinal Cord Injury
  • Infection
  • Compromised renal function

Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation

Location Details


Please Choose a site



Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Loading...